Head of North America
Doug joined Sinclair in November 2015 having supported Sinclair’s US launch activities as a consultant and brings over 25 years of experience in both commercialisation and executive leadership in medical devices, specialty pharma, and biotechnology. The majority of Doug’s career has been focused on aesthetics and dermatology and on launching new products and companies.
He lead the initial commercial efforts to bring BOTOX® to the aesthetic community while with Allergan and subsequently held senior leadership positions, including CEO roles, at a number of startup businesses and startup divisions of larger companies including Biogen and Suneva Medical. Doug’s experience spans leadership in sales and marketing, product development, and executive level oversight of all stages of the regulatory approval process, manufacturing, and finance. He holds a BA in Chemistry from Lafayette College and an MBA from Temple University.